Literature DB >> 7910273

Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat.

J Lopez-Miranda1, J M Ordovas, A Espino, C Marin, J Salas, F Lopez-Segura, J Jimenez-Pereperez, F Perez-Jimenez.   

Abstract

The plasma lipid response to changes in dietary fat and cholesterol can vary between individuals. At present, responders cannot be identified in advance. An adenine to guanine (A-->G) mutation in the promoter of the apolipoprotein A1 gene (apoA-1) has been suggested as affecting plasma high-density lipoprotein cholesterol. In 50 young men we examined the effect of the same mutation on the responses of both high and low density lipoprotein cholesterol to low-fat diet. The frequency for the A allele was 0.14. Subjects were fed a low-fat diet for 25 days, followed by a diet rich in monounsaturated fatty acid (MUFA, 22% out of 40% fat) for 28 days and lipoproteins were measured at the end of each diet. There were no differences in initial total cholesterol between subjects with the G/G mutation (170 mg/dL: 100 mg/dL = 2.59 mmol/L) and the G/A mutation (169 mg/dL) genotypes. After consumption of the high monounsaturated fat diet, significant increases were noted in plasma LDL cholesterol (10 mg/dL, p = 0.035) in the G/A subjects but not in the G/G subjects (1 mg/dL, p = 0.996). These differences showed that a significant diet-gene interaction (p = 0.015) existed. No differences were observed on HDL cholesterol between groups. Plasma low-density lipoprotein cholesterol responsiveness to diet may be explained by variation at the apoA-I gene locus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910273     DOI: 10.1016/s0140-6736(94)92149-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.

Authors:  X L Wang; S X Liu; R M McCredie; D E Wilcken
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

2.  The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction.

Authors:  Robert Block; James Corsetti; Ilan Goldenberg; Gabriel Vorobiof; Scott McNitt; Daniel Ryan; Wojciech Zareba; Arthur J Moss
Journal:  Heart Int       Date:  2009-06-30

3.  Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.

Authors:  T Wisniewski; A A Golabek; E Kida; K E Wisniewski; B Frangione
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 4.  Nutrigenomics in cardiovascular medicine.

Authors:  Dolores Corella; Jose M Ordovas
Journal:  Circ Cardiovasc Genet       Date:  2009-12

5.  Treatment of dyslipidemia: genetic interactions with diet and drug therapy.

Authors:  J M Ordovas; E J Schaefer
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

6.  The Effect of Interactions of Single Nucleotide Polymorphisms of APOA1/APOC3 with Food Group Intakes on the Risk of Metabolic Syndrome.

Authors:  Firoozeh Hosseini-Esfahani; Parvin Mirmiran; Maryam S Daneshpour; Azadeh Mottaghi; Fereidoun Azizi
Journal:  Avicenna J Med Biotechnol       Date:  2017 Apr-Jun

7.  [Nutrigenetics: potentials and applications in cardiovascular diseases and associated risk factors].

Authors:  Maria Daniela Defagó; Aldo Renato Eynard
Journal:  Rev Fac Cien Med Univ Nac Cordoba       Date:  2022-06-06

8.  ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties.

Authors:  Ali I Albahrani; Jannete J Usher; Mohammed Alkindi; Eileen Marks; L Ranganath; Said Al-yahyaee
Journal:  Lipids Health Dis       Date:  2007-08-06       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.